The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...
CNBC

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and ...
Los Angeles Times

What to know about psychedelic retreats, a booming business

This is read by an automated voice. Please report any issues or inconsistencies here. Hundreds of psychedelic retreats worldwide offer drug-assisted experiences for psychological healing, but the ...
CNN

FDA moves to fast-track review of psilocybin and methylone for mental health

Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on ...

While the FDA finalizes how to test drugs it treats like heroin, Mass. eyes psychedelic therapy

FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic ...
The Conversation

MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next

Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels. In 2023, ...